Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 556 AL 570

From obesity to Alzheimer's disease through insulin resistance

Terzo S, Amato A, Mulè F.

J Diabetes Complications. 2021 Nov;35(11):108026. doi: 10.1016/j.jdiacomp.2021.108026. Epub 2021 Aug 18.

Alzheimer disease and the periodontal patient: New insights, connections, and therapies

Ryder MI, Xenoudi P.

Periodontol 2000. 2021 Oct;87(1):32-42. doi: 10.1111/prd.12389.

Current druggable targets for therapeutic control of Alzheimer's disease

Gupta GL, Samant NP.

Contemp Clin Trials. 2021 Oct;109:106549. doi: 10.1016/j.cct.2021.106549. Epub 2021 Aug 28.

Neuropsychological deficits in Posterior Cortical Atrophy and typical Alzheimer's disease: A meta-analytic review

North C, Desai R, Saunders R, Suárez-González A, Bamiou D, Costafreda SG, de Haan G, Halls G, Heutink J, O'Nions E, Utoomprurkporn N, John A, Stott J.

Cortex. 2021 Oct;143:223-236. doi: 10.1016/j.cortex.2021.07.011. Epub 2021 Aug 6.

Mitochondrial links between brain aging and Alzheimer's disease

Wilkins HM, Swerdlow RH.

Transl Neurodegener. 2021 Sep 1;10(1):33. doi: 10.1186/s40035-021-00261-2.

Innate Immunity Protein IFITM3 in Alzheimer's Disease

Hur JY.

DNA Cell Biol. 2021 Nov;40(11):1351-1355. doi: 10.1089/dna.2021.0585. Epub 2021 Aug 31.

The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease

Yin X, Qiu Y, Zhao C, Zhou Z, Bao J, Qian W.

Med Sci Monit. 2021 Sep 2;27:e933084. doi: 10.12659/MSM.933084.

A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease

Bajad NG, Swetha R, Gutti G, Singh M, Kumar A, Singh SK.

Future Med Chem. 2021 Oct;13(19):1695-1711. doi: 10.4155/fmc-2021-0109. Epub 2021 Sep 2.

Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention

Takata K, Ginhoux F, Shimohama S.

Biochem Pharmacol. 2021 Oct;192:114754. doi: 10.1016/j.bcp.2021.114754. Epub 2021 Sep 1.

Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease

Xia H.

Drug Metab Rev. 2021 Nov;53(4):563-591. doi: 10.1080/03602532.2021.1977316. Epub 2021 Oct 1.

Gut Microbiota and Alzheimer's Disease: Experimental Evidence and Clinical Reality

Saha S, Singh S, Prasad S, Mittal A, Sharma AK, Chakrabarti S.

Curr Alzheimer Res. 2021;18(10):787-801. doi: 10.2174/1567205018666210907160854.

Distinct types of amyloid-β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease

Madhu P, Mukhopadhyay S.

J Cell Biochem. 2021 Nov;122(11):1594-1608. doi: 10.1002/jcb.30141. Epub 2021 Sep 7.

Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease

Ghosh N, Kundu LM.

Future Med Chem. 2021 Oct;13(20):1767-1794. doi: 10.4155/fmc-2021-0184. Epub 2021 Sep 9.

Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer's disease

Lew CH, Petersen C, Neylan TC, Grinberg LT.

Sleep Med Rev. 2021 Dec;60:101541. doi: 10.1016/j.smrv.2021.101541. Epub 2021 Aug 16.

RNA Dynamics in Alzheimer's Disease

Rybak-Wolf A, Plass M.

Molecules. 2021 Aug 24;26(17):5113. doi: 10.3390/molecules26175113.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias